{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:29:13Z","timestamp":1791919753839,"version":"4.3.4"},"reference-count":137,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s481420","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T08:58:50Z","timestamp":1730969930000},"page":"5041-5062","source":"Crossref","is-referenced-by-count":26,"title":["Optimizing Pharmacological and Immunological Properties of Therapeutic Proteins Through PEGylation: Investigating Key Parameters and Their Impact"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Jo\u00e3o","family":"Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Caliceti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","volume-title":"Protein-Based Therapeutics","year":"2023","DOI":"10.1007\/978-981-19-8249-1"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1016\/S0021-9258(17)40291-2","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"publisher","volume-title":"Peptide and Protein Delivery","year":"2011","DOI":"10.1016\/B978-0-12-384935-9.10011-2"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"8929715","DOI":"10.1155\/2022\/8929715","volume":"2022","author":"Zuma","year":"2022","journal-title":"Biomed Res Int"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/10717540600814402","volume":"13","author":"Hamidi","year":"2006","journal-title":"Drug Deliv"},{"key":"ref7","unstructured":"Biopharma PEG. FDA approved pegylated drugs by 2024; 2024. Available from: https:\/\/www.biochempeg.com\/article\/58.html. Accessed March 11, 2024."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2101633","DOI":"10.1002\/adfm.202101633","volume":"31","author":"Rondon","year":"2021","journal-title":"Adv Funct Mater"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s40265-019-01120-1","volume":"79","author":"Heo","year":"2019","journal-title":"Drugs"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","volume":"244","author":"Zhang","year":"2016","journal-title":"J Control Release"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cncr.22739","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer"},{"key":"ref12","unstructured":"European Medicines Agency (EMA). Elfabrio: summary of product characteristics (SmPC); 2023. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/elfabrio-epar-product-information_en.pdf. Accessed March 27, 2024."},{"key":"ref13","unstructured":"European Medicines Agency (EMA). Oncaspar: summary of product characteristics (SmPC); 2023. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/oncaspar-epar-product-information_en.pdf. Accessed March 27, 2024."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/jama.2011.1169","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1177\/0192623315591171","volume":"43","author":"Ivens","year":"2015","journal-title":"Toxicol Pathol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J Control Release"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/1389201023378175","volume":"3","author":"Koren","year":"2002","journal-title":"Curr Pharm Biotechnol"},{"key":"ref18","doi-asserted-by":"publisher","volume-title":"Advances in Protein Molecular and Structural Biology Methods","year":"2022","DOI":"10.1016\/B978-0-323-90264-9.00001-5"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2174\/1570163817666200312102137","volume":"18","author":"Sharker","year":"2021","journal-title":"Curr Drug Discov Technol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e0186211","DOI":"10.1371\/journal.pone.0186211","volume":"12","author":"Rup","year":"2017","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00299-021-02693-6","volume":"40","author":"Karki","year":"2021","journal-title":"Plant Cell Rep"},{"key":"ref23","unstructured":"U.S. Food and Drug Administration. Elelyso: highlights of prescribing information; 2012. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022458lbl.pdf. Accessed April 8, 2024."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ymgme.2014.08.002","volume":"114","author":"Kizhner","year":"2015","journal-title":"Mol Genet Metab"},{"key":"ref25","unstructured":"European Medicines Agency (EMA). Assessment report for Elfabrio (pegunigalsidasealfa) procedure no. EMEA\/H\/C\/005618\/0000; 2023. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/elfabrio-epar-public-assessment-report_en.pdf. Accessed March 14, 2024."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1042\/BSR20130081","volume":"33","author":"Tekoah","year":"2013","journal-title":"Biosci Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5483\/bmbrep.2015.48.8.101","volume":"48","author":"Oh","year":"2015","journal-title":"BMB Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"114079","DOI":"10.1016\/j.addr.2021.114079","volume":"180","author":"Shi","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40259-015-0127-4","volume":"29","author":"Arvedson","year":"2015","journal-title":"BioDrugs"},{"key":"ref30","volume-title":"Safety of Biologics Therapy","year":"2016"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e2121","DOI":"10.1210\/clinem\/dgz149","volume":"105","author":"Miller","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejpb.2022.02.006","volume":"172","author":"Hauptstein","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jimd.12080","volume":"42","author":"Schiffmann","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1177\/0091270007305299","volume":"47","author":"Ries","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"ref35","unstructured":"U.S. Food and Drug Administration. Fabrazyme: highlights of prescribing information; 2010. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/103979s5135lbl.pdf. Accessed May 15, 2024."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1353626","DOI":"10.3389\/fphar.2024.1353626","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"9S","DOI":"10.1592\/phco.23.9.9s.32888","volume":"23","author":"Zamboni","year":"2003","journal-title":"Pharmacotherapy"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","volume":"40","author":"Harris","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"ref39","unstructured":"U.S. Food and Drug Administration. Pegasys: highlights of prescribing information; 2011. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/103964s5204lbl.pdf. Accessed April 8, 2024."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/polym12020298","volume":"12","author":"Hoang Thi","year":"2020","journal-title":"Polymers (Basel)"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/s0169-409x(03)00108-x","volume":"55","author":"Caliceti","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/jps.2600830432","volume":"83","author":"Yamaoka","year":"1994","journal-title":"J Pharm Sci"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/dmd.106.012419","volume":"35","author":"Webster","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1006\/toxs.1997.2396","volume":"42","author":"Bendele","year":"1998","journal-title":"Toxicol Sci"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1177\/0192623312474726","volume":"41","author":"Rudmann","year":"2013","journal-title":"Toxicol Pathol"},{"key":"ref46","unstructured":"U.S. Food and Drug Administration. Cimzia: FDA pharmacology review; 2007. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/125160s000_PharmR_P1.pdf. Accessed April 9, 2024."},{"key":"ref47","unstructured":"U.S. Food and Drug Administration. Somavert: pharmacology report Part 2; 2002. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21-106_Somavert_Pharmr_P2.pdf. Accessed April 9, 2024."},{"key":"ref48","unstructured":"U.S. Food and Drug Administration. Krystexxa: pharmacology review; 2010. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/125293Orig1s000PharmR.pdf. Accessed April 9, 2024."},{"key":"ref49","unstructured":"European Medicines Agency (EMA). CHMP safety working party\u2019s response to the PDCO regarding the use of PEGylated drug products in the paediatric population; 2012. Available from: www.ema.europa.eu\/en\/documents\/scientific-guideline\/chmp-safety-working-partys-response-pdco-regarding-use-pegylated-drug-products-paediatric-population_en.pdf. Accessed March 28, 2024."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","volume":"105","author":"Turecek","year":"2016","journal-title":"J Pharm Sci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1021\/acs.bioconjchem.8b00133","volume":"29","author":"Ruderfer","year":"2018","journal-title":"Bioconjug Chem"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jconrel.2018.05.001","volume":"292","author":"B\u00f6ttger","year":"2018","journal-title":"J Control Release"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jconrel.2009.10.015","volume":"142","author":"Park","year":"2010","journal-title":"J Control Release"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e2202368","DOI":"10.1002\/adhm.202202368","volume":"12","author":"Mohammed","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"ref55","doi-asserted-by":"publisher","volume-title":"The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment","year":"2015","DOI":"10.1016\/B978-0-12-417144-2.00016-0"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000181877","volume":"35","author":"Rougeot","year":"1991","journal-title":"Horm Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s11095-005-8177-9","volume":"22","author":"Hermeling","year":"2005","journal-title":"Pharm Res"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/biot.200900218","volume":"5","author":"Jev\u0161evar","year":"2010","journal-title":"Biotechnol J"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.semarthrit.2020.04.011","volume":"50","author":"Schlesinger","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1021\/bc000082g","volume":"12","author":"Bailon","year":"2001","journal-title":"Bioconjug Chem"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e10600","DOI":"10.1002\/btm2.10600","volume":"9","author":"Gao","year":"2024","journal-title":"Bioeng Transl Med"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1007\/s12274-018-2131-8","volume":"11","author":"Lu","year":"2018","journal-title":"Nano Res"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.procbio.2017.08.004","volume":"63","author":"Wang","year":"2017","journal-title":"Process Biochem"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/bit.21482","volume":"98","author":"Fee","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s0169-409x(02)00022-4","volume":"54","author":"Roberts","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov Today"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1358\/dot.2009.45.9.1416421","volume":"45","author":"Pasut","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1089\/107999001317205240","volume":"21","author":"Grace","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1021\/bc049781","volume":"16","author":"Dhalluin","year":"2005","journal-title":"Bioconjug Chem"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/s0169-409x(02)00027-3","volume":"54","author":"Wang","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"ref72","unstructured":"U.S. Food and Drug Administration. Mircera: highlights of prescribing information; 2018. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/125164s078lbl.pdf. Accessed April 8, 2024."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.biomaterials.2018.04.050","volume":"178","author":"Liu","year":"2018","journal-title":"Biomaterials"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1021\/bc300594y","volume":"24","author":"da Silva Freitas","year":"2013","journal-title":"Bioconjug Chem"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1023\/a:1016042220817","volume":"13","author":"Kinstler","year":"1996","journal-title":"Pharm Res"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1134\/S0003683815070030","volume":"51","author":"Korzhavin","year":"2015","journal-title":"Appl Biochem Microbiol"},{"key":"ref77","unstructured":"U.S. Food and Drug Administration. Neulasta: highlights of prescribing information; 2018. Available from: https\/\/chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/125031s198lbl.pdf. Accessed March 28, 2024."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-16-0905","volume":"177","author":"Luo","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"821588","DOI":"10.3389\/fendo.2022.821588","volume":"13","author":"Wu","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref80","unstructured":"U.S. Food and Drug Administration. Plegridy: highlights of prescribing information; 2023. Available from: https:\/\/www.plegridy.com\/content\/dam\/commercial\/plegridy\/pat\/en_us\/pdf\/plegridy-prescribing-information.pdf. Accessed April 9, 2024."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jtice.2008.07.015","volume":"40","author":"Ho","year":"2009","journal-title":"J Taiwan Inst Chem Eng"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/protein\/12.7.535","volume":"12","author":"Petersen","year":"1999","journal-title":"Protein Eng"},{"key":"ref83","doi-asserted-by":"publisher","volume-title":"Polymer-Protein Conjugates","year":"2020","DOI":"10.1016\/B978-0-444-64081-9.00014-0"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF03261880","volume":"26","author":"Zhang","year":"2012","journal-title":"BioDrugs"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40259-020-00416-z","volume":"34","author":"Lee","year":"2020","journal-title":"BioDrugs"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11274-020-02829-y","volume":"36","author":"Doti","year":"2020","journal-title":"World J Microbiol Biotechnol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jab.2016.06.002","volume":"14","author":"Khameneh","year":"2016","journal-title":"J Appl Biomed"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/acs.bioconjchem.6b00468","volume":"27","author":"Spolaore","year":"2016","journal-title":"Bioconjug Chem"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/glycob\/cwl004","volume":"16","author":"DeFrees","year":"2006","journal-title":"Glycobiology"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000233309","volume":"70","author":"Richter","year":"1983","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0192-0561(85)90158-4","volume":"7","author":"Tsuji","year":"1985","journal-title":"Int J Immunopharmacol"},{"key":"ref92","first-page":"37","volume":"10","author":"Sroda","year":"2005","journal-title":"Cell Mol Biol Lett"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s40883-021-00198-y","volume":"8","author":"Freire Haddad","year":"2022","journal-title":"Regen Eng Transl Med"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","volume":"88","author":"Yang","year":"2016","journal-title":"Anal Chem"},{"key":"ref95","first-page":"11","volume":"17","author":"Rosenberg","year":"2004","journal-title":"BioPharm Int"},{"key":"ref96","unstructured":"U.S. Food and Drug Administration. Immunogenicity assessment for therapeutic protein products; 2014. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/immunogenicity-assessment-therapeutic-protein-products. Accessed March 27, 2024."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41467-017-00622-4","volume":"8","author":"Chang","year":"2017","journal-title":"Nat Commun"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1298473","DOI":"10.1155\/2016\/1298473","volume":"2016","author":"Kuriakose","year":"2016","journal-title":"J Immunol Res"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"102922","DOI":"10.1016\/j.esmoop.2024.102922","volume":"9","author":"Barroso","year":"2024","journal-title":"ESMO Open"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3389\/fimmu.2020.01301","volume":"11","author":"Jawa","year":"2020","journal-title":"Front Immunol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"115500","DOI":"10.1016\/j.jpba.2023.115500","volume":"234","author":"Di Ianni","year":"2023","journal-title":"J Pharm Biomed Anal"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"808606","DOI":"10.3389\/fimmu.2022.808606","volume":"13","author":"de Bourayne","year":"2022","journal-title":"Front Immunol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat Med"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1615\/CritRevImmunol.v30.i2.30","volume":"30","author":"Rong","year":"2010","journal-title":"Crit Rev Immunol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/1743-422X-9-274","volume":"9","author":"Liu","year":"2012","journal-title":"Virol J"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/jps.22276","volume":"100","author":"Singh","year":"2011","journal-title":"J Pharm Sci"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","volume":"9","author":"Garay","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1186\/ar4500","volume":"16","author":"Hershfield","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13075-017-1396-8","volume":"19","author":"Calabrese","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ebiom.2018.10.038","volume":"37","author":"Gupta","year":"2018","journal-title":"EBioMedicine"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"100968","DOI":"10.1016\/j.gim.2023.100968","volume":"25","author":"Hughes","year":"2023","journal-title":"Genet Med"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/jmg-2023-109445","volume":"61","author":"Wallace","year":"2024","journal-title":"J Med Genet"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaci.2021.05.020","volume":"149","author":"Bruusgaard-Mouritsen","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.4155\/bio.15.112","volume":"7","author":"Krishna","year":"2015","journal-title":"Bioanalysis"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s42004-020-00369-y","volume":"3","author":"Huckaby","year":"2020","journal-title":"Commun Chem"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0021-9258(19)69965-5","volume":"256","author":"Bishop","year":"1981","journal-title":"J Biol Chem"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1073\/pnas.85.11.3903","volume":"85","author":"Bishop","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13059-017-1207-1","volume":"18","author":"Matzaraki","year":"2017","journal-title":"Genome Biol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3389\/fimmu.2018.01269","volume":"9","author":"Gubbels Bupp","year":"2018","journal-title":"Front Immunol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40259-023-00641-2","volume":"38","author":"Harris","year":"2024","journal-title":"BioDrugs"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"S422","DOI":"10.1513\/AnnalsATS.201602-095AW","volume":"13","author":"Weyand","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"ref122","unstructured":"U.S. Food and Drug Administration. Jivi: highlights of prescribing information; 2018. Available from: https:\/\/www.fda.gov\/files\/vaccines,%20blood%20%26%20biologics\/published\/Package-Insert-JIVI.pdf. Accessed March 28, 2024."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1021\/bc000119x","volume":"12","author":"Caliceti","year":"2001","journal-title":"Bioconjug Chem"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1021\/bc200551b","volume":"23","author":"Sherman","year":"2012","journal-title":"Bioconjug Chem"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1248\/bpb.b13-00661","volume":"37","author":"Zhang","year":"2014","journal-title":"Biol Pharm Bull"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000233512","volume":"74","author":"Richter","year":"1984","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.1016\/j.vaccine.2022.08.024","volume":"40","author":"Carre\u00f1o","year":"2022","journal-title":"Vaccine"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/vaccines11061118","volume":"11","author":"Xu","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/jimd.12668","volume":"46","author":"Bernat","year":"2023","journal-title":"J Inherit Metab Dis"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"100002","DOI":"10.1016\/j.ejcped.2022.100002","volume":"1","author":"Broos","year":"2023","journal-title":"EJC Paediatric Oncology"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.0.CO;2-1","volume":"86","author":"Symon","year":"1999","journal-title":"Cancer"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/annonc\/mdh097","volume":"15","author":"O\u2019Brien","year":"2004","journal-title":"Ann Oncol"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.005","volume":"354","author":"Ishida","year":"2008","journal-title":"Int J Pharm"},{"key":"ref134","unstructured":"U.S. Food and Drug Administration. Moderna COVID-19 vaccine EUA fact sheet for recipients and caregivers; 2022. Available from: https:\/\/www.fda.gov\/media\/144638\/download. Accessed April 9, 2024."},{"key":"ref135","unstructured":"U.S. Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine fact sheet for healthcare providers administering vaccine; 2023. Available from: https:\/\/www.fda.gov\/media\/167211\/download. Accessed April 10, 2024."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.2147\/IJN.S82481","volume":"10","author":"Wang","year":"2015","journal-title":"Int J Nanomed"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci Technol Adv Mater"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/97095","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/97095","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T08:59:03Z","timestamp":1730969943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/optimizing-pharmacological-and-immunological-properties-of-therapeutic-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":137,"URL":"https:\/\/doi.org\/10.2147\/dddt.s481420","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}